Obeticholic acid regulatory update

Intercept said it submitted an NDA to FDA and that EMA accepted an MAA for obeticholic acid to treat primary biliary cirrhosis (PBC) as monotherapy in adults unable to tolerate ursodeoxycholic acid (U...